Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034935

Chief Financial Officer bought 125,000 shares at $0.26 ($32,338)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hunt Jonathan Robert Chief Financial Officer 2023-12-18 Purchase +125,000 $0.26 $32,338 316,710 D: show line 1 in the form
Open-market purchases · 125,000 sh · avg $0.26 · $32,338
Loading xslF345X05/rdgdoc.xml…